In Chile, the forecasted mortality rate for genitourinary system diseases among men is predicted to show a continuous decline from 2024 to 2028. The anticipated values begin at 24.7 deaths per hundred thousand men in 2024 and decrease incrementally to 22.8 by 2028. Examining the year-on-year percentage variations reveals a steady decrease in mortality rates, averaging around 1.3% annually. In 2023, the actual rates serve as a baseline reference point for this downward trend, which provided a comparative understanding. The compounded annual growth rate (CAGR) illustrates a consistent average decline of approximately 1.6% over the five-year forecast period.
Future trends to watch for include advancements in medical treatments, early detection technologies, and public health initiatives targeting risk factors associated with genitourinary diseases. These factors could further accelerate the reduction in mortality rates, enhancing overall male health outcomes in Chile.
